| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.2 | 0.1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |